Antibiotic Development for Patients with Serious Infections and Unmet Need

First Page		Document Content
Biology Infectious diseases Microbiology Colistin Antibiotic resistance Antimicrobial Infection Antibacterial Acinetobacter Medicine Health Antibiotics		Antibiotic Development for Patients with Serious Infections and Unmet Need Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 1,04 MB Share Document on Facebook

	TABLA 4 PRUEBAS PUNTUALES PARA ORGANISMOS1 SELECCIONADOS Organismo Acinetobacter spp. DocID: 1sgse - View Document
	K-392 Rapid Identification of Live Acinetobacter spp. in Bronchoalveolar Lavage Specimens by Automated Immunofluorescence Microscopy K. Hance, D. Howson, M. Lindsey, T. Ngo, S. Metzger Accelr8 Technology Corp., Denver, DocID: 1sfFf - View Document
	S WITCHING OFF B ACTERIAL R ESISTANCE The target evaluation platform revealed an AdeR unrelated tigecycline resistance mechanism in XDR Acinetobacter baumannii Vincent Trebosc1,2, Sarah Gartenmann1, Kevin Royet1, Pablo DocID: 1seHr - View Document
	CRapid Quantitation and Identification of Pseudomonas aeruginosa, Staphylococcus aureus, and Acinetobacter baumannii In Bronchoalveolar Lavage Fluid Steve Metzger DocID: 1sc3l - View Document
	C-065 A Rapid Indirect Enzyme-Linked Immunosorbent Assay for Identification of Acinetobacter spp. From Cultured Isolates K. Hance, D. Howson, M. Lindsey, S. Metzger, T. Ngo, A. Trahan DocID: 1rglR - View Document